Our Services
Medical Information
Helpful Resources
Published on: 3/5/2026
Still feeling anxious on fluvoxamine can be normal because SSRIs can take weeks to reach full effect, and factors like suboptimal dosing, temporary activation, coexisting conditions, and triggers such as stress, poor sleep, or caffeine can keep symptoms going. There are several factors to consider; see below to understand more.
Medically approved next steps include giving it adequate time if safe, talking to your clinician about dosing or augmentation, adding CBT or ERP, optimizing sleep and caffeine, checking for medical causes, and seeking urgent care for red flags like suicidal thoughts or signs of serotonin syndrome, with complete guidance outlined below.
If you're still feeling anxious while taking fluvoxamine, you're not alone. Many people expect anxiety to disappear quickly after starting medication. When that doesn't happen, it can feel discouraging — or even scary.
The good news: there are clear medical reasons why this can happen, and there are evidence‑based next steps that can help.
Let's walk through what may be going on in your brain and what you can safely do next.
Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI). It's FDA‑approved for obsessive‑compulsive disorder (OCD) and is also commonly prescribed for:
Fluvoxamine works by increasing levels of serotonin, a brain chemical that helps regulate mood, anxiety, sleep, and emotional stability.
However, serotonin balance doesn't change overnight.
SSRIs like fluvoxamine typically take:
During the first few weeks, anxiety can sometimes feel worse before it gets better. This happens because serotonin changes affect multiple brain circuits before they stabilize.
If you recently started fluvoxamine or had a dose increase, your brain may still be adjusting.
Fluvoxamine dosing varies widely depending on the condition being treated.
If your dose is too low, you may get partial relief. If it's too high, side effects can increase anxiety-like symptoms such as:
This is sometimes called activation syndrome, and it's a known early SSRI effect.
Medication addresses brain chemistry — but anxiety isn't only chemical.
It can also be influenced by:
If these factors aren't addressed, fluvoxamine may only partially help.
Research consistently shows that medication plus therapy works better than medication alone for many anxiety disorders.
Cognitive behavioral therapy (CBT) is particularly effective because it:
Fluvoxamine can lower the "volume" of anxiety, but therapy helps rewire the response system.
Persistent anxiety despite treatment may signal:
For example, in bipolar disorder, antidepressants alone can worsen anxiety or agitation. That's why accurate diagnosis matters.
If you're experiencing symptoms that don't seem to match your current diagnosis or you're unsure what's really driving your anxiety, Ubie's free AI-powered Anxiety Symptom Checker can help you understand your symptoms better and prepare meaningful questions before your next doctor's appointment.
Most lingering anxiety is not dangerous — but certain symptoms require urgent medical attention.
Seek immediate care or speak to a doctor right away if you experience:
These are rare but serious.
If you're still anxious on fluvoxamine, here's what evidence‑based guidelines recommend.
If you're early in treatment and symptoms are tolerable:
Stopping fluvoxamine abruptly can cause withdrawal symptoms such as dizziness, irritability, and flu-like feelings.
Your provider may:
Never adjust your dose on your own.
If fluvoxamine alone isn't enough, doctors sometimes add:
These decisions depend on your specific diagnosis and risk factors.
CBT is strongly supported by clinical research for anxiety disorders.
Other helpful therapies include:
Medication changes brain chemistry. Therapy changes brain pathways.
Together, they are often more powerful.
These are not "quick fixes," but they matter.
Sleep
Caffeine
Exercise
Alcohol
Ask your doctor if testing is appropriate for:
Treating underlying medical issues can significantly reduce anxiety.
Not every SSRI works for every person.
If after an adequate trial (usually 8–12 weeks at a therapeutic dose) symptoms remain significant, your doctor may suggest:
This is common and does not mean treatment has failed. Finding the right medication is sometimes a process of careful adjustment.
If you're still anxious on fluvoxamine, it does not mean:
Anxiety disorders are highly treatable conditions. Sometimes they just require fine-tuning.
The key is collaboration with a healthcare professional — not stopping medication suddenly or suffering in silence.
Contact a doctor urgently if you experience:
If something feels serious or dangerous, do not wait.
Fluvoxamine is a well-studied, evidence-based treatment for anxiety and OCD. But like all psychiatric medications, it works differently for each person.
If you're still anxious:
You deserve relief — and there are structured, medically approved pathways to get there.
Before your next doctor's visit, consider using Ubie's free AI-powered Anxiety Symptom Checker to track your symptoms and generate a clear summary you can share with your healthcare provider — it takes just a few minutes and can make your appointment more productive.
Most importantly, speak to a doctor about persistent, worsening, or potentially life‑threatening symptoms. Anxiety is treatable, but serious symptoms require professional evaluation.
With the right approach, improvement is not just possible — it's likely.
(References)
* Baldwin DS, et al. Management of treatment-resistant anxiety disorders. World J Biol Psychiatry. 2018 May;19(4):254-266. doi: 10.1080/15622975.2017.1407027. PMID: 29775086.
* Maron E, et al. Neurobiological Mechanisms of Treatment Resistance in Anxiety Disorders. Curr Top Behav Neurosci. 2021;52:277-299. doi: 10.1007/7858_2021_211. PMID: 34160472.
* Bandelow B, et al. Augmentation strategies in treatment-resistant anxiety disorders: A systematic review and meta-analysis. J Affect Disord. 2020 May 1;268:210-221. doi: 10.1016/j.jad.2020.02.042. PMID: 32095697.
* Chen S, et al. Pharmacogenomics of selective serotonin reuptake inhibitors in anxiety disorders: a systematic review. J Neural Transm (Vienna). 2019 Nov;126(11):1533-1544. doi: 10.1007/s00702-019-02096-3. PMID: 31742416.
* Roesler C, et al. The pathophysiology of generalized anxiety disorder: a comprehensive review. Dialogues Clin Neurosci. 2020 Mar;22(1):15-28. doi: 10.31887/DCNS.2020.22.1/croesler. PMID: 32267675.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.